Table 2.
Treatment | Monoclonal antibodies | |||||||
---|---|---|---|---|---|---|---|---|
CD54 | CD80 | CD86 | HLA-DR | |||||
%, SDa | P | %, SDa | P | %, SDa | P | %, SDa | P | |
Control | 75.5 (0.83) | — | 19.9 (0.83) | — | 13.1 (0.20) | — | 5.2 (0.26) | — |
Metamizole 1 µM | 97.7 (0.57) | 0.00* | 17.6 (0.61) | 0.018* | 10.1 (0.6) | 0.001* | 4.13 (0.49) | 0.03* |
Metamizole 10 µM | 97.3 (0.2) | 0.00* | 14.4 (1.24) | 0.003* | 8.8 (0.1) | 0.00* | 3.8 (0.36) | 0.006* |
Dexketoprofen 1 µM | 97 (0.8) | 0.00* | 14.4 (1.24) | 0.003* | 9.7 (1.05) | 0.005* | 4.43 (0.75) | 0.17 |
Dexketoprofen 10 µM | 98.2 (0.15) | 0.00* | 17 (2.36) | 0.11 | 11.2 (0.96) | 0.06 | 5.56 (1.74) | 0.73 |
Ketorolac 1 µM | 98.2 (0.17) | 0.00* | 16.3 (2.13) | 0.11 | 13.43 (4.38) | 0.926 | 5.76 (1.77) | 0.63 |
Ketorolac 10 µM | 97.6 (0.1) | 0.00* | 16.6 (2.13) | 0.055 | 10.2 (0.45) | 0.001* | 4.73 (0.58) | 0.27 |
Acetylsalicylic acid 1 µM | 98.1 (0.5) | 0.00* | 18.8 (2.45) | 0.51 | 11.8 (1.37) | 0.24 | 5.06 (0.35) | 0.627 |
Acetylsalicylic acid 10 µM | 98.3 (0.36) | 0.00* | 18.8 (0.45) | 0.12 | 11.2 (1.49) | 0.09 | 5.26 (0.46) | 0.839 |
aStandard deviation, *significant differences P < 0.05.
Bold values is the statistical significance.